Citation Impact
Citing Papers
Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 Deacetylase
2004 StandoutScience
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Regulation of the Cell Cycle at the G1–S Transition by Proteolysis of Cyclin E and p27Kip1
2001
Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.
2003
Hallmarks of Cancer: The Next Generation
2011 Standout
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
CDK inhibitors: positive and negative regulators of G1-phase progression
1999 Standout
Cell-cycle inhibitor p27/Kip-1 expression in non-astrocytic and non-oligodendrocytic human nervous system tumors
1999
The RB and p53 pathways in cancer
2002 Standout
Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene
2003 StandoutNobel
p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells
1999
AKT/PKB Signaling: Navigating Downstream
2007 Standout
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
2003 Standout
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Cell-cycle checkpoints and cancer
2004 StandoutNature
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
The ubiquitin-proteasome pathway in cancer
1998
Regulation of the Cdk inhibitor p27 and its deregulation in cancer
2000
Novel Imaging Provides New Insights into Mechanisms of Oxygen Transport in Tumors
2009
Role of the SCFSkp2 Ubiquitin Ligase in the Degradation of p21Cip1 in S Phase
2003 StandoutNobel
The biology and management of non-small cell lung cancer
2018 StandoutNature
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
The Cytoplasmic Shuttling and Subsequent Degradation of p27Kip1 Mediated by Jab1/CSN5 and the COP9 Signalosome Complex
2002
Prognostic significance of p27Kip1 expression in colorectal cancer: a clinico-pathological characterization
1999
Report From the International Atomic Energy Agency (IAEA) Consultants' Meeting on Elective Nodal Irradiation in Lung Cancer: Non–Small-Cell Lung Cancer (NSCLC)
2008
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
2005 StandoutNature
Induction Chemotherapy with Carboplatin, Irinotecan, and Paclitaxel Followed by High Dose Three-Dimension Conformal Thoracic Radiotherapy (74 Gy) with Concurrent Carboplatin, Paclitaxel, and Gefitinib in Unresectable Stage IIIA and Stage IIIB Non-small Cell Lung Cancer
2008
Smad-dependent and Smad-independent pathways in TGF-β family signalling
2003 StandoutNature
Three Different Binding Sites of Cks1 Are Required for p27-Ubiquitin Ligation
2002 StandoutNobel
The Hedgehog and Wnt signalling pathways in cancer
2001 StandoutNature
Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress
2002 StandoutNature
A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase
2001 Nature
Delivery technologies for cancer immunotherapy
2019 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Identification of the Ubiquitin Carrier Proteins, E2s, Involved in Signal-induced Conjugation and Subsequent Degradation of IκBα
1999 StandoutNobel
Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey
2010
A Protein Conjugation System in Yeast with Homology to Biosynthetic Enzyme Reaction of Prokaryotes
2000 StandoutNobel
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
Hypoxia Inhibits G1/S Transition through Regulation of p27 Expression
2001 StandoutNobel
Expression of cell cycle inhibitor p27Kip1 and its inactivator Jab1 in melanocytic lesions
2004
Prevention of Venous Thromboembolism
2004 Standout
Discovery of an oncogenic activity in p27Kip1that causes stem cell expansion and a multiple tumor phenotype
2007
The Oncogenic Activity of Cyclin E Is Not Confined to Cdk2 Activation Alone but Relies on Several Other, Distinct Functions of the Protein
2002
Expression of Cyclin‐dependent Kinase Inhibitor p27/Kipl and AP‐1 Coactivator p38/Jabl Correlates with Differentiation of Embryonal Rhabdomyosarcoma
2002
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
2004 Standout
Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression
2000 StandoutNobel
Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1
1997
Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): A meta-analysis of individual data from 1764 patients
2006
Prevention of Venous Thromboembolism
2008 Standout
Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN
2001
Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex
2004 StandoutNatureNobel
Selection of Mutant CHO Cells with Constitutive Activation of the HIF System and Inactivation of the von Hippel-Lindau Tumor Suppressor
2001 StandoutNobel
Cell cycle, CDKs and cancer: a changing paradigm
2009 Standout
The role of senescent cells in ageing
2014 StandoutNature
Inverse relation between levels of p27Kip1 and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas
2001 StandoutNobel
The Retinoblastoma Protein Pathway in Cell Cycle Control and Cancer
1997
Association of the Cyclin-dependent Kinases and 14-3-3 Sigma Negatively Regulates Cell Cycle Progression
2000
PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest
2002
The Tumor Suppressor Protein p16 and the Human Papillomavirus Oncoprotein-58 E7 Are Naturally Occurring Lysine-less Proteins That Are Degraded by the Ubiquitin System
2004 StandoutNobel
Proteolysis and the G1-S transition: the SCF connection
1998
A ubiquitin-like system mediates protein lipidation
2000 StandoutNatureNobel
Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer
2002
Multiple Functions of Jab1 Are Required for Early Embryonic Development and Growth Potential in Mice
2004 StandoutNobel
The ubiquitin-mediated proteolytic pathway: Mode of action and clinical implications
2000 StandoutNobel
The C-terminal Region of an Apg7p/Cvt2p Is Required for Homodimerization and Is Essential for Its E1 Activity and E1-E2 Complex Formation
2001 StandoutNobel
Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer
2004
p27kip1: A Multifunctional Cyclin-Dependent Kinase Inhibitor with Prognostic Significance in Human Cancers
1999
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Peptidic degron in EID1 is recognized by an SCF E3 ligase complex containing the orphan F-box protein FBXO21
2015 StandoutNobel
Rbx1, a Component of the VHL Tumor Suppressor Complex and SCF Ubiquitin Ligase
1999 StandoutScienceNobel
FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal
2002
Skp2 is oncogenic and overexpressed in human cancers
2001
Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma.
1998
The Prognostic Significance of Altered Cyclin-Dependent Kinase Inhibitors in Human Cancer
1999
Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non–Small-Cell Lung Cancer: The Hoosier Oncology Group and U.S. Oncology
2008
Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors.
2001
The von Hippel–Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal
1998
The Pezcoller lecture: cancer cell cycles revisited.
2000
Surfing the p53 network
2000 StandoutNature
The ubiquitin-proteasome pathway: on protein death and cell life
1998 StandoutNobel
Signal Transduction by the TGF-β Superfamily
2002 StandoutScience
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
2002 StandoutNobel
Altered ubiquitination and stability of aquaporin-1 in hypertonic stress
2001 StandoutNobel
Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer
2002
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1).
2003
Cyclin-Dependent Kinase Pathways As Targets for Cancer Treatment
2006
Works of Yee Ung being referenced
Phase III Trial of Maintenance Gefitinib or Placebo After Concurrent Chemoradiotherapy and Docetaxel Consolidation in Inoperable Stage III Non–Small-Cell Lung Cancer: SWOG S0023
2008
Comparison of the efficacy and acute toxicity of weekly versus daily chemoradiotherapy for non–small-cell lung cancer: a meta-analysis
2003
Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer
1997
The impact of 18 FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study
2002
Positron Emission Tomography-Computed Tomography Compared with Invasive Mediastinal Staging in Non-small Cell Lung Cancer: Results of Mediastinal Staging in the Early Lung Positron Emission Tomography Trial
2011
Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18 FDG-hybrid PET fusion
2001
Accelerated hypofractionation for early-stage non-small-cell lung cancer
2002
18Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis and Staging of Lung Cancer: A Systematic Review
2007
Immune Checkpoint Inhibitors for Patients With Advanced Non–Small-Cell Lung Cancer: A Systematic Review
2017
Randomized, Double-Blind, Placebo-Controlled Trial of Erythropoietin in Non–Small-Cell Lung Cancer With Disease-Related Anemia
2007
Updated analysis of SWOG 0023: A randomized phase III trial of gefitinib versus placebo maintenance after definitive chemoradiation followed by docetaxel in patients with locally advanced stage III non-small cell lung cancer
2007
Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update
2017